跳至主要内容
临床试验/JPRN-UMIN000003708
JPRN-UMIN000003708已完成4 期

A feasibility study of adjuvant therapy with FOLFOX plus Ca/Mg for the patient with colorectal cancer - A feasibility study of adjuvant therapy with FOLFOX plus Ca/Mg for the patient with colorectal cancer(KSCC0903)

Kyushu Study group of Clinical Cancer0 个研究点目标入组 48 人开始时间: 2010年7月14日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who had received blood transfusion, blood products, or hematopoietic growth factors such as granulocyte-colony stimulating factor within 7 days prior to registration. 2.History of the severe hypersensitivity. 3.Sensory neuropathy. 4.Active other malignancies. 5.Active infection 6.History of mental disorder,central nerve disorder. 7.Watery stools or Grade 2 or more diarrhea 8.Requiring steroid drug 9.Pregnant or lactating woman 10.Co-mobility, such as interstitial lung disease, lung fibrosis, intestinal paralysis, ileus,uncontrolled diabetes, liver cirrhosis, viral hepatitis type B ,kidney failure, uncontrolled hypertension, history of cardiac infarction 11.History of the internal organ transplant 12.Hypercalcemia ,renal calculus 13.Requiring cardiac glycoside 14.High probability of recurrence 15.Not appropriate for the study at the physician's assessment

研究者

发起方
Kyushu Study group of Clinical Cancer

相似试验